Characterization, Safety and Functional Assessment Of Silver Nanoparticle-Mediated CRISPR/Cas9 Against HIV
Authors:
- Cheng Heng WongCWCheng Heng Wong
- Nor Hazwani AhmadNANor Hazwani Ahmad
- Matthew Tze Jian WongMWMatthew Tze Jian Wong
- Kumitaa Theva DasKDKumitaa Theva Das
- 16 November 2026
- journal article
- Published by Springer Nature in BioNanoScience
- Vol. 16 (12)
Abstract
No abstract availableFunding Information
- Universiti Sains Malaysia (R501-LR-RND003-0001458-0000)
This publication has 39 references indexed in Scilit:
- In Vivo Safety Evaluation of Silver Nanoparticle Encapsulated CRISPR/Cas9: Implications for HIV Gene TherapyBioNanoScience, 2026
- Smart inorganic nanoparticles in nanomedicine: Strategies for synthesis and functionalizationInternational Journal of Pharmaceutics, 2025
- Magnetic Nanoparticle‐Assisted Non‐Viral CRISPR‐Cas9 for Enhanced Genome Editing to Treat Rett SyndromeAdvanced Science, 2024
- Engineered mRNA Delivery Systems for Biomedical ApplicationsAdvanced Materials, 2024
- Latent HIV-1 provirus in vitro suppression using combinatorial CRISPR/Cas9 strategyGene Reports, 2022
- Strategy for Cytoplasmic Delivery Using Inorganic ParticlesPharmaceutical Research, 2022
- In vitro and in vivo toxicity assessment of nanoparticlesInternational Nano Letters, 2017
- CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral EscapeCell Reports, 2016
- Fluorescent Silver Nanoclusters in Condensed DNAChemphyschem, 2013
- Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cellsBiomedical Microdevices, 2007